Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

Clinical trial NCT00256880 · COMPLETED

Trial details

NCT number: NCT00256880
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2005-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.